March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 17, 2026

ALS Trial Tests Celecoxib–Ciprofloxacin Combination

Dual-drug therapy showed signals of slower disease progression and reduced complications in patients with ALS.

Conexiant

March 17, 2026

Aneurysmal Hemorrhage Triggers Systemic Effects

Researchers examine physiologic responses following rupture and link them to outcomes.

Conexiant

March 12, 2026

The 60 Percent Diagnostic Gap in M/E

What earlier mNGS testing could mean for labs and clinicians

The Pathologist

March 11, 2026

Sudden Vision Loss: Could It Be Pituitary Apoplexy?

Case report highlights delayed treatment and persistent visual loss in a patient with pituitary adenoma

Conexiant

March 10, 2026

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

Conexiant

March 09, 2026

Newborn Vitamin K Refusal Trends

Investigators examine trends in newborn vitamin K refusal and associated neurologic outcomes.

Conexiant

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

February 26, 2026

How Sleep Disruption Affects Male Fertility 

Review links insomnia, sleep apnea, and circadian disruption to impaired spermatogenesis.

Conexiant